5-Chloro-3-(1H-imidazol-1-yl)-1,2,4-thiadiazole → HCID 58654443, compound
Reaction equation
[NH2:1][CH:2]([CH:17]([CH3:19])[CH3:18])[C:3]([NH:5][CH2:6][CH2:7][C:8]1[CH:16]=[CH:15][C:11]2[O:12][CH2:13][O:14][C:10]=2[CH:9]=1)=[O:4].Cl[C:21]1[S:25][N:24]=[C:23]([N:26]2[CH:30]=[CH:29][N:28]=[CH:27]2)[N:22]=1>CS(C)=O.C(N(CC)CC)C.[Cl-].[Na+].O>[O:12]1[C:11]2[CH:15]=[CH:16][C:8]([CH2:7][CH2:6][NH:5][C:3](=[O:4])[C@H:2]([NH:1][C:21]3[S:25][N:24]=[C:23]([N:26]4[CH:30]=[CH:29][N:28]=[CH:27]4)[N:22]=3)[CH:17]([CH3:19])[CH3:18])=[CH:9][C:10]=2[O:14][CH2:13]1Participants
Procedure
2-Amino-N-(2-benzo[1,3]dioxol-5-yl-ethyl)-3-methyl-butyramide (135 mg, 0.51 mmol) was dissolved in DMSO (2 mL) and triethylamine (150 μL). Next, the 5-chloro-3-imidazol-1-yl-[1,2,4]thiadiazole (95.1 mg, 0.51 mmol) was added to the reaction vessel and it was stirred at room temperature for 16 hours. After this period, a portion of brine (50 mL) was added and the mixture was transferred to a separatory funnel and extracted with ethyl acetate (75 mL). The organic layer was dried over Na2SO4 and concentrated under vacuum. The crude material was purified by Flash Chromatography (0-50% ACN/DCM gradient) to afford 20.4 mg of pure product, N-(2-benzo[1,3]dioxol-5-yl-ethyl)-2-(3-imidazol-1-yl-[1,2,4]thiadiazol-5-ylamino)-3-methyl-butyramide. [M+H]+ 414.84; 1H NMR (400 MHz, CDCl3) δ 8.52 (s, 1H), 7.71 (s, 1H), 6.99 (s, 1H), 6.62-6.52 (m, 3H), 5.82-5.80 (m, 2H), 4.0 (Br s, 1H), 3.64-3.47 (m, 3H), 2.76-2.72 (m, 2H), 2.30-2.29 (m, 1H), 1.03-1.01 (m, 6H).
Workup
- waitAfter this period
- customthe mixture was transferred to a separatory funnel
- extractionextracted with ethyl acetate (75 mL)
- dry with materialThe organic layer was dried over Na2SO4
- concentrationconcentrated under vacuum
- customThe crude material was purified by Flash Chromatography (0-50% ACN/DCM gradient)
Sources & evidence
- ORD record
- ord-a144b203bcff4a659f2f71632e42d90b
- Source dataset
- uspto-grants-2010_11
- Patent number
- US07825256B2
Reaction notes
Loading…